NCT06274840View on ClinicalTrials.gov

COVID-19 Antibody Responses In Cystic Fibrosis

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 8, 2022

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions
COVID-19Cystic Fibrosis
Trial Locations (1)

1800-268

RECRUITING

CHLN, Lisbon

All Listed Sponsors
collaborator

Queen's University, Belfast

OTHER

collaborator

European Cystic Fibrosis Society - Clinical Trials Network

OTHER

collaborator

Cystic Fibrosis Foundation

OTHER

collaborator

Medical University Innsbruck

OTHER

lead

Pilar Azevedo

OTHER

NCT06274840 - COVID-19 Antibody Responses In Cystic Fibrosis | Biotech Hunter | Biotech Hunter